Author: WeWorldMedia-admin

Russian GRU Targeting Western Logistics Entities and Technology Companies

Published: 12 May 2025
Categories: US-Computer Emergency Readiness Team

RSS feed source: US Computer Emergency Readiness Team

Executive Summary

This joint cybersecurity advisory (CSA) highlights a Russian state-sponsored cyber campaign targeting Western logistics entities and technology companies. This includes those involved in the coordination, transport, and delivery of foreign assistance to Ukraine. Since 2022, Western logistics entities and IT companies have faced an elevated risk of targeting by the Russian General Staff Main Intelligence Directorate (GRU) 85th Main Special Service Center (85th GTsSS), military unit 26165—tracked in the cybersecurity community under several names (see “Cybersecurity Industry Tracking”). The actors’ cyber espionage-oriented campaign, targeting technology companies and logistics entities, uses a mix of previously disclosed tactics, techniques, and procedures (TTPs). The authoring agencies expect similar targeting and TTP use to continue.

Executives and network defenders at logistics entities and technology companies should recognize the elevated threat of unit 26165 targeting, increase monitoring and threat hunting for known TTPs and indicators of compromise (IOCs), and posture network defenses with a presumption of targeting.

This cyber espionage-oriented campaign targeting logistics entities and technology companies uses a mix of previously disclosed TTPs and is likely connected to these actors’ wide scale targeting of IP cameras in Ukraine and bordering NATO nations.

The following authors and co-sealers are releasing this CSA:

United States National Security Agency (NSA) United States Federal Bureau of Investigation (FBI) United Kingdom National Cyber Security Centre (NCSC-UK) Germany Federal

Click this link to continue reading the article on the source website.

Residential electric bills in Hawaii and Connecticut are twice those in New Mexico, Utah

Published: 12 May 2025
Categories: US Energy Information Administration

RSS feed source: US Computer Emergency Readiness Team

In-brief analysis

May 12, 2025

The average electric monthly bill for U.S. residential customers was $144 in 2024, but average costs for customers in some states were much higher or lower. Customers in states such as Hawaii and Connecticut, where retail electricity prices are relatively high, paid more than $200 per month for electricity, or more than twice as much as customers in states such as New Mexico and Utah.

Monthly electricity bills are the product of two factors: retail electricity prices and the amount of grid-delivered electricity that customers consume. Although we do not directly survey retail electricity prices or bills in our monthly electricity surveys, we estimate bills by dividing the utilities’ revenue from residential customers by the number of residential customers. Similarly, we estimate retail prices by dividing utility revenue from residential customers by

Click this link to continue reading the article on the source website.

Lab-synthesized botanical compound shows promise for fighting aggressive breast cancer

Published: 8 May 2025
Categories: National Science Foundation

RSS feed source: US Computer Emergency Readiness Team

Chemists funded by the U.S. National Science Foundation have developed a new process to synthesize a plant-based compound that shows effectiveness against triple-negative breast cancer cells. According to the American Cancer Society, triple-negative breast cancer is one of the most aggressive types of breast cancer and accounts for 10-15% of all breast cancer cases. The process also increases the compound’s potency against these cancer cells and provides a method for it to be mass-produced to enable further testing as a potential treatment.

The new process can also be used broadly to help discover new medicines by synthesizing and testing other complex organic compounds. The findings were achieved by Emory University researchers and published in The Journal of the American Chemical Society.

The compound — called phaeocaulisin A — is extracted from the flowering plant Curcuma phaeocaulis, a relative of ginger and turmeric used for centuries in traditional medicine.

“We not only efficiently replicated a complex natural product, we also improved upon it by turning it into a more potent compound,” says Mingji Dai, professor of chemistry and co-lead of the study.

“It is only the first step in a long process,” says Yong Wan, professor of pharmacology and chemical biology and study co-lead. “But the new analogue of phaeocaulisin A we have reported shows promising efficacy against triple-negative breast cancer cells, which are very aggressive and

Click this link to continue reading the article on the source website.